Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Multidrug combination therapy has long been a vital approach for treating complex diseases by leveraging synergistic effects between drugs. However, drug-drug interactions (DDIs) are not uniformly beneficial. Accurate and rapid identification of DDIs is critical to mitigate drug-related side effects. Currently, many computational-based methods have been used to expedite the prediction of DDIs. However, most of these methods use a single perspective to obtain drug features, which have limited expressive capabilities and cannot fully represent the essential attributes of drugs. In this study, we propose the Multi-view Feature Embedding for drug-drug interaction prediction (MFE-DDI), which integrates SMILES information, molecular graph data and atom spatial semantic information to model drugs from multiple perspectives and encapsulate the intricate drug information crucial for predicting DDIs. Concurrently, the feature information extracted from different feature encoding channels is fused in the attention-based fusion module to fully convey the essence of drugs. Consequently, this approach enhances the efficacy of the DDI prediction task. Experimental results indicate that MFE-DDI surpasses other baseline methods on three datasets. Moreover, analysis experiments demonstrate the robustness of the model and the necessity of each component of the model. Case studies on newly approved drugs demonstrate the effectiveness of our method in real scenarios. The code and data used in MFE-DDI can be found at https://github.com/2019040445/MFE_DDI.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181007PMC
http://dx.doi.org/10.1016/j.csbj.2025.05.029DOI Listing

Publication Analysis

Top Keywords

multi-view feature
8
feature encoding
8
drug-drug interaction
8
interaction prediction
8
drugs
5
mfe-ddi
4
mfe-ddi multi-view
4
feature
4
encoding framework
4
framework drug-drug
4

Similar Publications

Mammography is a primary method for early screening, and developing deep learning-based computer-aided systems is of great significance. However, current deep learning models typically treat each image as an independent entity for diagnosis, rather than integrating images from multiple views to diagnose the patient. These methods do not fully consider and address the complex interactions between different views, resulting in poor diagnostic performance and interpretability.

View Article and Find Full Text PDF

Drug-target interaction (DTI) identification is of great significance in drug development in various areas, such as drug repositioning and potential drug side effects. Although a great variety of computational methods have been proposed for DTI prediction, it is still a challenge in the face of sparsely correlated drugs or targets. To address the impact of data sparsity on the model, we propose a multi-view neighborhood-enhanced graph contrastive learning approach (MneGCL), which is based on graph clustering according to the adjacency relationship in various similarity networks between drugs or targets, to fully exploit the information of drugs and targets with few corrections.

View Article and Find Full Text PDF

Diagnostic ultrasound has long filled a crucial niche in medical imaging thanks to its portability, affordability, and favorable safety profile. Now, multi-view hardware and deep-learning-based image reconstruction algorithms promise to extend this niche to increasingly sophisticated applications, such as volume rendering and long-term organ monitoring. However, progress on these fronts is impeded by the complexities of ultrasound electronics and by the scarcity of high-fidelity radiofrequency data.

View Article and Find Full Text PDF

Motivation: Therapeutic peptide is an important ingredient in the treatment of various diseases and drug discovery. The toxicity of peptides is one of the major challenges in peptide drug therapy. With the abundance of therapeutic peptides generated in the post-genomics era, it is a challenge to promptly identify toxicity peptides using computational methods.

View Article and Find Full Text PDF

Sparse Partial Least Squares (sPLS) is a common dimensionality reduction technique for data fusion, which projects data samples from two views by seeking linear combinations with a small number of variables with the maximum variance. However, sPLS extracts the combinations between two data sets with all data samples so that it cannot detect latent subsets of samples. To extend the application of sPLS by identifying a specific subset of samples and remove outliers, we propose an $\ell _\infty /\ell _{0}$-norm constrained weighted sparse PLS ($\ell _\infty /\ell _{0}$-wsPLS) method for joint sample and feature selection, where the $\ell _\infty /\ell _{0}$-norm constrains are used to select a subset of samples.

View Article and Find Full Text PDF